Clinical Burden and Healthcare Utilization Associated with Hospitalizations of RSV-Infected Polish Children During the 2022/23 Season
Viruses · 2025
DOI: 10.3390/v18010060 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Viruses, 2025. Verfasst von Jan Mazela und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Poznan University of Medical Sciences in Poznan, 60-535 Poznań, Poland. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization, Patient Acceptance of Health Care. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi and AstraZeneca, Sanofi.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract illness and hospitalizations in children aged ≤5 years worldwide. The aim of this study was to characterize the Polish population of patients aged ≤5 years who were hospitalized due to RSV infection, focusing on their clinical and epidemiological characteristics as well as treatment patterns.
Methods
This retrospective observational study was conducted between November 2023 and February 2024 in 41 hospitals with pediatric departments across Poland. Data from patients aged ≤5 years admitted due to RSV infection confirmed with antigen test or RT-PCR were collected. The dataset was weighted and extrapolated to allow conclusions applicable to the general population of patients aged 0–5 years hospitalized with RSV infection in Poland.
Results
Data from 419 patients were analyzed. Over half (57.4%) were younger than 12 months, 84% were born at term, and 85.8% had no comorbidities. The most frequent manifestations of RSV infections were pneumonia (56.8%), bronchiolitis (35.9%), and bronchitis (12.4%). Viral co-infections were identified in 8% of patients. Regarding treatment, 21.1% of patients required respiratory support, 67.6% received inhaled steroid therapy, 61.5% were treated with antibiotics, 48.1% received beta2-mimetics and anticholinergics, and 44.3% underwent systemic steroid therapy.
Conclusions
Our findings confirm that severe RSV primarily affects the youngest children with no comorbidities who do not present high risk conditions. To reduce the overall disease burden, preventive strategies should be offered to all children, not being limited to those in risk groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology, Poznan University of Medical Sciences in Poznan, 60-535 Poznań, Poland.
- Department of Pediatrics, Collegium Medicum, University of Zielona Góra, 65-046 Zielona Góra, Poland.
- Department of Pediatrics, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
- Department of Pharmacoeconomics, Hospital Infection Control Team, Institute of Mother and Child, 01-211 Warsaw, Poland.
- Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, 01-211 Warsaw, Poland.
- Sanofi A/S, Vaccines Medical Affairs, DK-2100 København, Denmark.
ORCID-Profile: Jan Mazela, Teresa Jackowska, Marcin Czech, Anna Smaga, Joanna Glazewska, Jacek Wysocki
Förderung
- Sanofi and AstraZeneca
- Sanofi
Zitieren
APA
Mazela, J., Jackowska, T., Czech, M., Helwich, E., Martyn, O., Aleksiejuk, P., Smaga, A., Tkacz, A., Glazewska, J., & Wysocki, J. (2025). Clinical Burden and Healthcare Utilization Associated with Hospitalizations of RSV-Infected Polish Children During the 2022/23 Season. Viruses. https://doi.org/10.3390/v18010060
Vancouver
Mazela J, Jackowska T, Czech M, Helwich E, Martyn O, Aleksiejuk P, et al. Clinical Burden and Healthcare Utilization Associated with Hospitalizations of RSV-Infected Polish Children During the 2022/23 Season. Viruses. 2025. doi:10.3390/v18010060
BibTeX
@article{Mazela2025,
author = {Mazela, Jan and Jackowska, Teresa and Czech, Marcin and Helwich, Ewa and Martyn, Oliver and Aleksiejuk, Pawel and Smaga, Anna and Tkacz, Andrzej and Glazewska, Joanna and Wysocki, Jacek},
title = {Clinical Burden and Healthcare Utilization Associated with Hospitalizations of RSV-Infected Polish Children During the 2022/23 Season},
journal = {Viruses},
year = {2025},
doi = {10.3390/v18010060}
}
EUVIMED